we evaluated a total of 177 patients with small cell bronchogenic carcinoma , treated by five successive regimens of combination chemotherapy , consisting of either cyclophosphamide and vincristine alone or with doxorubicin or doxorubicin plus bacillus calmette-guerin ( bcg ) or doxorubicin plus methotrexate , for a number of prognostic factors ( age , sex , extent of disease , performance status , sites and number of metastases , serum ldh and alkaline phosphatase , weight loss , leukopenia , and thrombopenia ) .
C0013089
doxorubicin
C0281523
doxorubicin